{
    "clinical_study": {
        "@rank": "117882", 
        "arm_group": [
            {
                "arm_group_label": "Fluorouracil and folinic acid", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Observation", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells. It is\n      not yet known which treatment regimen is more effective for colorectal cancer.\n\n      PURPOSE: Randomized phase III trial to compare the effectiveness of immediate with delayed\n      fluorouracil plus leucovorin in treating patients with advanced colorectal cancer without\n      signs or symptoms of disease."
        }, 
        "brief_title": "Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease", 
        "completion_date": {
            "#text": "February 2009", 
            "@type": "Actual"
        }, 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare survival and quality of life in asymptomatic patients with advanced\n      colorectal cancer randomized to immediate fluorouracil/leucovorin (5-FU/CF) vs. 5-FU/CF\n      delayed until onset of symptoms.\n\n      OUTLINE: Randomized, unblinded study. Arm I: Single-Agent Chemotherapy with Drug Modulation.\n      Fluorouracil, 5-FU, NSC-19893; with Leucovorin calcium, CF, NSC-3590. Arm II: Observation\n      followed by Single-Agent Chemotherapy with Drug Modulation. Clinical observation until\n      symptomatic; followed by 5-FU; with CF.\n\n      PROJECTED ACCRUAL: 144 patients will be entered over 4 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically or cytologically confirmed cancer of the colon or\n        rectum that is locally advanced or metastatic Primary lesion was or is located in the\n        large bowel as confirmed by endoscopy, radiology, or surgery Radiologic or clinical\n        evidence of metastasis subsequent to resection does not require histologic or cytologic\n        confirmation unless: Interval between primary surgery and development of metastasis is\n        greater than 5 years OR Primary cancer was Dukes' A or B1 Ineligible for potentially\n        curative therapy, e.g.: Surgical resection of a limited hepatic or pulmonary metastasis\n        Irradiation of locally recurrent colon or rectal cancer No or minimal symptoms related to\n        the cancer, i.e.: No persistent pain requiring regular narcotic analgesia No persistent\n        fever greater than 38 degrees C No symptomatic bowel obstruction No persistent nausea\n        requiring medication No weight loss of greater than 5 kg over the previous 3 months unless\n        clearly not associated with the cancer (e.g., associated with surgery or intercurrent\n        illness) Symptomatic relapse/metastases rendered asymptomatic by secondary surgery or\n        radiotherapy are eligible provided the patient remains asymptomatic for at least 6 weeks\n        following such treatment No CNS metastases No significant ascites, pleural effusion, or\n        pericardial effusion\n\n        PATIENT CHARACTERISTICS: Age: Adult under 80 (i.e., of legal age to sign own informed\n        consent according to institutional policy) Performance status: Karnofsky 90-100% ECOG 0\n        Hematopoietic: Granulocytes at least 1,500/mm3 Platelet count at least 100,000/mm3\n        Hepatic: Bilirubin no greater than upper limit of normal Renal: Creatinine less than 2.26\n        mg/dL Cardiovascular: No arrhythmia Other: No infection No other medical condition that is\n        uncontrolled or could be aggravated by the protocol therapy No prior or concurrent second\n        cancer except: Nonmelanomatous skin cancer In situ cervical cancer No pregnant women\n        Adequate contraception required of fertile patients Blood/body fluid analyses to determine\n        eligibility and quality-of-life questionnaire completed within 14 days prior to\n        randomization; imaging studies of sites of disease completed within 28 days prior to\n        randomization\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior\n        chemotherapy for metastatic disease or local recurrence Prior fluorouracil-based or other\n        adjuvant therapy allowed At least 6 months required between completion of therapy and\n        documentation of metastasis or recurrence Endocrine therapy: Not specified Radiotherapy:\n        Prior radiotherapy allowed Surgery: Prior surgery allowed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "79 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "67", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002570", 
            "org_study_id": "CO10", 
            "secondary_id": [
                "CAN-NCIC-CO10", 
                "NCCTG-JCO10", 
                "NCCTG-JCO.10", 
                "NCI-V94-0463", 
                "CDR0000063607"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Fluorouracil and folinic acid", 
                "description": "425 mg/m2 IV by bolus injection daily for 5 consecutive days q 28 days", 
                "intervention_name": "fluorouracil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Fluorouracil and folinic acid", 
                "description": "20 mg/m2 IV - number of cycles is determined by patient and physician", 
                "intervention_name": "leucovorin calcium", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluorouracil", 
                "Leucovorin", 
                "Levoleucovorin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "stage III colon cancer", 
            "stage IV colon cancer", 
            "stage III rectal cancer", 
            "stage IV rectal cancer", 
            "recurrent colon cancer", 
            "recurrent rectal cancer"
        ], 
        "lastchanged_date": "September 20, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/CAN-NCIC-CO10"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85259-5404"
                    }, 
                    "name": "CCOP - Scottsdale Oncology Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peoria", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61602"
                    }, 
                    "name": "CCOP - Illinois Oncology Research Association"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Urbana", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61801"
                    }, 
                    "name": "CCOP - Carle Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cedar Rapids", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52403-1206"
                    }, 
                    "name": "CCOP - Cedar Rapids Oncology Project"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Des Moines", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "10309-1016"
                    }, 
                    "name": "CCOP - Iowa Oncology Research Association"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sioux City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "51101-1733"
                    }, 
                    "name": "Siouxland Hematology-Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70121"
                    }, 
                    "name": "CCOP - Ochsner"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48106"
                    }, 
                    "name": "CCOP - Ann Arbor Regional"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duluth", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55805"
                    }, 
                    "name": "CCOP - Duluth"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Mayo Clinic Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Cloud", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "56303"
                    }, 
                    "name": "CentraCare Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bismarck", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58501"
                    }, 
                    "name": "Quain & Ramstad Clinic, P.C."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fargo", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58122"
                    }, 
                    "name": "CCOP - Merit Care Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grand Forks", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58201"
                    }, 
                    "name": "Altru Health Systems"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rapid City", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57709"
                    }, 
                    "name": "Rapid City Regional Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sioux Falls", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57105-1080"
                    }, 
                    "name": "CCOP - Sioux Community Cancer Consortium"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A PHASE III STUDY OF IMMEDIATE VERSUS DELAYED CHEMOTHERAPY FOR ASYMPTOMATIC ADVANCED COLORECTAL CANCER", 
        "overall_official": [
            {
                "affiliation": "Princess Margaret Hospital, Canada", 
                "last_name": "Malcolm J. Moore, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Mayo Clinic", 
                "last_name": "Henry C. Pitot, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2000", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Survival", 
            "safety_issue": "No", 
            "time_frame": "8 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002570"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "citation": "Hummer A, Carlo W, Sullivan D, et al.: Extensive hepatic resection does not correlate with toxicity following adjuvant chemotherapy. [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-526, 2002."
        }, 
        "secondary_outcome": [
            {
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "8 years"
            }, 
            {
                "measure": "Toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "8 years"
            }, 
            {
                "measure": "Time to progression", 
                "safety_issue": "No", 
                "time_frame": "8 years"
            }, 
            {
                "measure": "response rate", 
                "safety_issue": "No", 
                "time_frame": "8 years"
            }, 
            {
                "measure": "response duration", 
                "safety_issue": "No", 
                "time_frame": "8 years"
            }
        ], 
        "source": "NCIC Clinical Trials Group", 
        "sponsors": {
            "collaborator": {
                "agency": "North Central Cancer Treatment Group", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "NCIC Clinical Trials Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 1994", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2011"
    }, 
    "geocoordinates": {
        "Altru Health Systems": "47.925 -97.033", 
        "CCOP - Ann Arbor Regional": "42.281 -83.743", 
        "CCOP - Carle Cancer Center": "40.111 -88.207", 
        "CCOP - Cedar Rapids Oncology Project": "41.978 -91.666", 
        "CCOP - Duluth": "46.787 -92.1", 
        "CCOP - Illinois Oncology Research Association": "40.694 -89.589", 
        "CCOP - Iowa Oncology Research Association": "41.601 -93.609", 
        "CCOP - Merit Care Hospital": "46.877 -96.79", 
        "CCOP - Ochsner": "29.951 -90.072", 
        "CCOP - Scottsdale Oncology Program": "33.494 -111.926", 
        "CCOP - Sioux Community Cancer Consortium": "43.55 -96.7", 
        "CentraCare Clinic": "45.554 -94.17", 
        "Mayo Clinic Cancer Center": "44.022 -92.47", 
        "Quain & Ramstad Clinic, P.C.": "46.808 -100.784", 
        "Rapid City Regional Hospital": "44.081 -103.231", 
        "Siouxland Hematology-Oncology": "42.5 -96.4"
    }
}